alkotinib (ZG0418) / Suzhou Zelgen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Mar 6, 2024   
    P1,  N=17, Completed, 
    N=104 --> 4 | Recruiting --> Terminated; Sponsor R&D Strategy Adjustment Recruiting --> Completed
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion date, Trial primary completion date, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Apr 3, 2023   
    P1,  N=18, Recruiting, 
    Trial completion date: Aug 2023 --> Aug 2024 | Trial primary completion date: Jun 2023 --> Jun 2024 Trial completion date: May 2023 --> May 2024 | Trial primary completion date: Feb 2023 --> Feb 2024
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion date, Trial primary completion date, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Nov 29, 2022   
    P1,  N=18, Recruiting, 
    Trial completion date: Aug 2022 --> Aug 2023 | Trial primary completion date: Jun 2022 --> Jun 2023 Trial completion date: May 2022 --> May 2023 | Trial primary completion date: Feb 2022 --> Feb 2023
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion date, Trial primary completion date, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Jun 22, 2021   
    P1,  N=18, Recruiting, 
    Trial completion date: May 2022 --> May 2023 | Trial primary completion date: Feb 2022 --> Feb 2023 Trial completion date: May 2021 --> May 2022 | Trial primary completion date: Feb 2021 --> Feb 2022
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion, Trial completion date, Trial primary completion date:  To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects (clinicaltrials.gov) -  Jul 7, 2020   
    P1,  N=16, Completed, 
    Trial completion date: May 2021 --> May 2022 | Trial primary completion date: Feb 2021 --> Feb 2022 Not yet recruiting --> Completed | Trial completion date: May 2021 --> Dec 2019 | Trial primary completion date: Jan 2021 --> Dec 2019
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion date, Trial primary completion date, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Jul 2, 2020   
    P1,  N=18, Recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: May 2020 --> May 2021 | Trial primary completion date: Feb 2020 --> Feb 2021
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Trial completion date, Trial primary completion date, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Jan 2, 2020   
    P1,  N=18, Recruiting, 
    Trial completion date: May 2020 --> May 2021 | Trial primary completion date: Feb 2020 --> Feb 2021 Trial completion date: Jan 2020 --> May 2020 | Trial primary completion date: Sep 2019 --> Feb 2020
  • ||||||||||  alkotinib (ZG0418) / Suzhou Zelgen
    Enrollment open, Metastases:  Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer (clinicaltrials.gov) -  Apr 3, 2019   
    P1,  N=18, Recruiting, 
    Trial completion date: Nov 2019 --> May 2020 | Trial primary completion date: Oct 2019 --> Jan 2020 Not yet recruiting --> Recruiting